The chronic disease management market is anticipated to flourish at a steady CAGR of 13.4% between 2023 and 2033. The market is expected to hold a market share of USD 16.83 billion by 2033 while the market is likely to reach a value of USD 4.77 billion in 2023.
The rising chronic disease management market growth can be attributed to increasing awareness regarding the effects of ailments along with favorable health insurance policies. The market for chronic disease management registered a CAGR of 10.0% in the historical period from 2018 to 2022.
In chronic care management, patients are aware of reliable treatment options and the adoption of chronic disease management rises as patients are thoroughly guided to choose appropriate physicians and treatments to cure the disease. However, there is no specified condition for the patient to provide chronic disease management. Chronic disease management is generally provided in long-term care centers and rehabilitation centers. This improves the quality of care for patients through various means.
Chronic disease management providers make the patient aware of the available reimbursement scenario and help them with Medicare and Medicaid guidance. This, in turn, helps patients to claim their respective allowances. If the patients are opting for chronic disease management, there is a strong possibility that patients get the appropriate treatments at cheap prices and also get the benefit of allocated reimbursement.
| Attributes | Details |
|---|---|
| Chronic Disease Management Market CAGR (2023 to 2033) | 13.4% |
| Chronic Disease Management Market Size (2023) | USD 4.77 billion |
| Chronic Disease Management Market Size (2033) | USD 16.83 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The chronic disease management market size is projected to expand to a significant extent over the forecast period due to increasing awareness of people to avail of these services. In addition, there is huge competition among the leading providers in this market.
Both leading and local service provider offers various scheme to compete in the market. Further, chronic disease management service is gaining traction due to the use of health information technologies and improved availability of online resources in healthcare.
The increasing prevalence of chronic diseases such as asthma, COPD, cancer, diabetes, stroke, or musculoskeletal diseases around the globe is the key factor driving the growth of the chronic disease management market. Besides that, increasing awareness regarding healthcare management has also upsurged the demand for chronic disease management over the forecast period.
Improved services by service providers have increased the demand for chronic disease management in the market. Further, the growth in the medical tourism sector and the rise in healthcare IT solutions have fueled the progression of chronic disease management market trends and forecasts.
High investment required to establish the infrastructure and data security concerns related to cloud-based solutions can also hamper the progress of the chronic disease management market. Moreover, inadequate patient engagement and lack of interoperability are responsible for the sluggish growth of this market.
Principal Consultant
| Country | Revenue Share % (2022) |
|---|---|
| The United States | 38.4% |
| Germany | 5.9% |
| Japan | 3.8% |
| North America | 44.1% |
| Europe | 29.7% |
| Country | CAGR % (2023 to 2033) |
|---|---|
| China | 19.4% |
| India | 15.9% |
| Australia | 14.1% |
North America is expected to be an attractive market for chronic disease management due to the availability of advanced healthcare infrastructure in the United States. In addition, the increasing geriatric population in North America is fueling the growth of chronic disease management in the region. Health insurance policies are also contributing to the growth of the market. Thus, due to the aforementioned reasons, North America held a 44.1% market share for the chronic disease management market in 2022.
Many countries in Europe are affected by cardiovascular diseases. This is leading to people gaining problems with diabetes and obesity. Moreover, cardiovascular diseases are also a key reason for increasing death in the region. This has led to people investing in health insurance policies to manage illnesses better.
Quick and efficient reimbursement facilities are positively influencing the growth of the market in the region. Thus, owing to the reasons mentioned above, Europe held a 29.7% chronic disease management market share in 2022.
| Category | By Delivery Type |
|---|---|
| Leading Segment | On-premise |
| Market Share (2022) | 54.3% |
| Category | By End User Type |
|---|---|
| Leading Segment | Providers |
| Market Share (2022) | 58.8% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key start-ups for chronic disease management are Care Clinic, EveryDose, Pathmate, TheBigPicture, and Phable.
It tracks 12 primary human systems, including organs, tissues, and cellular biometrics to assist users in tracking, organizing, maintaining, and improving their health. It includes features like personalized food programs to monitor health indicators and prevent chronic diseases.
Leading service providers in this market are focusing on collaboration and partnership with healthcare stakeholders to provide patient-centric care, in turn bringing about emerging trends in the chronic disease management market. For instance:
The market held a value of USD 4.31 billion in 2022.
The market holds a value of USD 4.77 billion in 2023.
The market is anticipated to hold a share of USD 16.83 billion by 2033.
The market is expected to have a CAGR of 13.4% by 2033.
The on-premise segment leads the market as it held a market share of 54.3% in 2022.
The providers segment leads the market as it held a market share of 58.8% in 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Service Type 5.1. Consulting Services 5.2. Implementation Services 5.3. Educational Services 5.4. Other Service Types 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Delivery Mode 6.1. On-premise 6.2. Web-based 6.3. Cloud-based 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Providers 7.2. Payers 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. TriZetto Corporation 18.2. Phytel Inc. 18.3. Pegasystems Inc. 18.4. EXL Healthcare 18.5. AxisPoint Health 18.6. Wellcentive, Inc. 18.7. Medecision, Inc. 18.8. i2i Systems, Inc. 18.9. HealthSmart Holdings, Inc. 18.10. Allscripts Healthcare Solutions, Inc. 18.11. ZeOmega Inc. 18.12. Epic Corporation Inc. 18.13. Harmony Information Systems, Inc. 19. Assumptions & Acronyms Used 20. Research Methodology
Healthcare
January 2023
REP-GB-16435
299 pages
Explore Healthcare Insights
View Reports
Chronic Disease Management Market
